Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KOMAL JHAVERI

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1871822288
CMS profile
445348
Location
NEW YORK, NY

General Payments · PY2018–2024

$490,742.71

  • Reported across 325 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$174,257.49

91 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $39,199.30 19
Daiichi Sankyo Company LTD $38,400.96 9
Eli Lilly and Company $16,949.50 13
Daiichi Sankyo Inc. $14,978.85 6
Gilead Sciences, Inc. $14,975.14 6
AstraZeneca UK Limited $12,494.95 12
Genentech USA, Inc. $8,698.24 5
F. Hoffmann-La Roche AG $7,600.00 1
Stemline Therapeutics Inc. $5,001.59 5
Merck Sharp & Dohme Corporation $4,622.71 5
Genentech, Inc. $3,892.07 5
Novartis Pharma AG $2,700.00 1
Lilly USA, LLC $2,400.00 1
NOVARTIS PHARMACEUTICALS CORPORATION $2,344.18 3

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $13,101.61 19
PY2019 $10,178.39 14
PY2020 $27,196.20 17
PY2021 $39,261.15 23
PY2022 $92,025.34 60
PY2023 $134,722.53 101
PY2024 $174,257.49 91

Payment records · PY2024 (91)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $9,932.50 01/04/2024 Consulting Fee Undisputed 01/23/2026 1104710701 CMS
AstraZeneca Pharmaceuticals LP $685.00 01/04/2024 Consulting Fee Undisputed 01/23/2026 1105888509 CMS
AstraZeneca Pharmaceuticals LP $2,740.00 01/05/2024 Consulting Fee Undisputed 01/23/2026 1105393894 CMS
AstraZeneca Pharmaceuticals LP $8,905.00 01/25/2024 Consulting Fee Undisputed 01/23/2026 1105754049 CMS
AstraZeneca Pharmaceuticals LP $2,055.00 01/29/2024 Consulting Fee Undisputed 01/23/2026 1104516580 CMS
AstraZeneca Pharmaceuticals LP $1,370.00 02/14/2024 Consulting Fee Undisputed 01/23/2026 1105677213 CMS
AstraZeneca Pharmaceuticals LP $130.80 03/07/2024 Food and Beverage Undisputed 01/23/2026 1105766118 CMS
AstraZeneca Pharmaceuticals LP $47.06 03/09/2024 Food and Beverage Undisputed 01/23/2026 1105235797 CMS
AstraZeneca Pharmaceuticals LP $63.35 03/18/2024 Food and Beverage Undisputed 01/23/2026 1105405774 CMS
AstraZeneca Pharmaceuticals LP $685.00 05/07/2024 Consulting Fee Undisputed 01/23/2026 1104382303 CMS
AstraZeneca Pharmaceuticals LP $75.00 05/31/2024 Food and Beverage Undisputed 01/23/2026 1104298202 CMS
AstraZeneca Pharmaceuticals LP $25.00 05/31/2024 Food and Beverage Undisputed 01/23/2026 1105718252 CMS
AstraZeneca Pharmaceuticals LP $3,767.50 06/25/2024 Consulting Fee Undisputed 01/23/2026 1104218797 CMS
AstraZeneca Pharmaceuticals LP $2,055.00 08/01/2024 Consulting Fee Undisputed 01/23/2026 1104653459 CMS
AstraZeneca Pharmaceuticals LP $4,110.00 10/18/2024 Consulting Fee Undisputed 01/23/2026 1105238796 CMS
AstraZeneca Pharmaceuticals LP $1,370.00 10/22/2024 Consulting Fee Undisputed 01/23/2026 1104680347 CMS
AstraZeneca Pharmaceuticals LP $685.00 11/07/2024 Consulting Fee Undisputed 01/23/2026 1104220133 CMS
AstraZeneca Pharmaceuticals LP $48.09 12/12/2024 Food and Beverage Undisputed 01/23/2026 1105883673 CMS
AstraZeneca Pharmaceuticals LP $450.00 12/20/2024 Consulting Fee Undisputed 01/23/2026 1105828879 CMS
AstraZeneca UK Limited $45.03 05/14/2024 Food and Beverage Undisputed 01/23/2026 1094051651 CMS
AstraZeneca UK Limited $3,253.75 06/28/2024 Consulting Fee Undisputed 01/23/2026 1093964580 CMS
AstraZeneca UK Limited $1,712.50 08/09/2024 Consulting Fee Undisputed 01/23/2026 1094033206 CMS
AstraZeneca UK Limited $685.00 08/30/2024 Consulting Fee Undisputed 01/23/2026 1093965731 CMS
AstraZeneca UK Limited $42.42 09/12/2024 Food and Beverage Undisputed 01/23/2026 1093881499 CMS
AstraZeneca UK Limited $31.93 09/12/2024 Food and Beverage Undisputed 01/23/2026 1093918787 CMS
AstraZeneca UK Limited $13.40 09/12/2024 Food and Beverage Undisputed 01/23/2026 1093979038 CMS
AstraZeneca UK Limited $13.40 09/12/2024 Food and Beverage Undisputed 01/23/2026 1094017798 CMS
AstraZeneca UK Limited $85.08 09/12/2024 Travel and Lodging Undisputed 01/23/2026 1094037681 CMS
AstraZeneca UK Limited $104.94 09/12/2024 Travel and Lodging Undisputed 01/23/2026 1094046639 CMS
AstraZeneca UK Limited $685.00 11/06/2024 Consulting Fee Undisputed 01/23/2026 1093919202 CMS
AstraZeneca UK Limited $5,822.50 12/19/2024 Consulting Fee Undisputed 01/23/2026 1094003303 CMS
Daiichi Sankyo Company LTD $32.00 02/21/2024 Food and Beverage Undisputed 01/23/2026 1075869786 CMS
Daiichi Sankyo Company LTD $9,935.16 02/25/2024 Travel and Lodging Undisputed 01/23/2026 1075869778 CMS
Daiichi Sankyo Company LTD $454.00 02/25/2024 Travel and Lodging Undisputed 01/23/2026 1075869798 CMS
Daiichi Sankyo Company LTD $5,000.00 04/02/2024 Consulting Fee Undisputed 01/23/2026 1075869788 CMS
Daiichi Sankyo Company LTD $865.77 11/22/2024 Travel and Lodging Undisputed 01/23/2026 1075869832 CMS
Daiichi Sankyo Company LTD $136.57 11/22/2024 Food and Beverage Undisputed 01/23/2026 1075869834 CMS
Daiichi Sankyo Company LTD $11,124.93 11/24/2024 Travel and Lodging Undisputed 01/23/2026 1075869824 CMS
Daiichi Sankyo Company LTD $852.53 11/24/2024 Travel and Lodging Undisputed 01/23/2026 1075869828 CMS
Daiichi Sankyo Company LTD $10,000.00 12/27/2024 Consulting Fee Undisputed 01/23/2026 1075869840 CMS
Daiichi Sankyo Inc. $17.62 05/17/2024 Food and Beverage Undisputed 01/23/2026 1089438253 CMS
Daiichi Sankyo Inc. $11,493.60 05/17/2024 Travel and Lodging Undisputed 01/23/2026 1089438255 CMS
Daiichi Sankyo Inc. $625.00 05/29/2024 Consulting Fee Undisputed 01/23/2026 1089438251 CMS
Daiichi Sankyo Inc. $744.95 06/19/2024 Travel and Lodging Undisputed 01/23/2026 1089438245 CMS
Daiichi Sankyo Inc. $385.18 06/19/2024 Travel and Lodging Undisputed 01/23/2026 1089438249 CMS
Daiichi Sankyo Inc. $1,712.50 12/12/2024 Consulting Fee Undisputed 01/23/2026 1089438247 CMS
Eli Lilly and Company $2,400.00 02/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135117521 CMS
Eli Lilly and Company $1,200.00 02/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135125298 CMS
Eli Lilly and Company $1,600.00 02/08/2024 Consulting Fee Undisputed 01/23/2026 1135115455 CMS
Eli Lilly and Company $22.25 06/01/2024 Food and Beverage Undisputed 01/23/2026 1135138096 CMS
Eli Lilly and Company $11.88 09/14/2024 Food and Beverage Undisputed 01/23/2026 1135079896 CMS
Eli Lilly and Company $17.07 09/14/2024 Food and Beverage Undisputed 01/23/2026 1135115457 CMS
Eli Lilly and Company $800.00 09/17/2024 Consulting Fee Undisputed 01/23/2026 1135125300 CMS
Eli Lilly and Company $3,200.00 09/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135117523 CMS
Eli Lilly and Company $3,200.00 10/17/2024 Consulting Fee Undisputed 01/23/2026 1135134822 CMS
Eli Lilly and Company $1,600.00 11/27/2024 Consulting Fee Undisputed 01/23/2026 1135109138 CMS
Eli Lilly and Company $1,600.00 12/04/2024 Consulting Fee Undisputed 01/23/2026 1135109140 CMS
Eli Lilly and Company $41.55 12/10/2024 Food and Beverage Undisputed 01/23/2026 1135134820 CMS
Eli Lilly and Company $1,256.75 12/13/2024 Travel and Lodging Undisputed 01/23/2026 1135137104 CMS
F. Hoffmann-La Roche AG $7,600.00 09/16/2024 Consulting Fee Undisputed 01/23/2026 1133049328 CMS
Genentech USA, Inc. $407.85 03/14/2024 Travel and Lodging Undisputed 01/23/2026 1133049332 CMS
Genentech USA, Inc. $208.72 03/14/2024 Food and Beverage Undisputed 01/23/2026 1133049336 CMS
Genentech USA, Inc. $7,790.00 03/14/2024 Consulting Fee Undisputed 01/23/2026 1133049341 CMS
Genentech USA, Inc. $185.00 03/14/2024 Travel and Lodging Undisputed 01/23/2026 1133049345 CMS
Genentech USA, Inc. $106.67 10/18/2024 Food and Beverage Undisputed 01/23/2026 1133049324 CMS
Genentech, Inc. $55.52 09/16/2024 Food and Beverage Undisputed 01/23/2026 1133049349 CMS
Genentech, Inc. $1,250.00 09/16/2024 Consulting Fee Undisputed 01/23/2026 1133049352 CMS
Genentech, Inc. $44.70 09/16/2024 Food and Beverage Undisputed 01/23/2026 1133049365 CMS
Genentech, Inc. $2,470.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1133049356 CMS
Genentech, Inc. $71.85 12/09/2024 Food and Beverage Undisputed 01/23/2026 1133049361 CMS
Gilead Sciences, Inc. $123.55 02/09/2024 Food and Beverage Undisputed 01/23/2026 1133841126 CMS
Gilead Sciences, Inc. $4,020.00 02/15/2024 Consulting Fee Undisputed 01/23/2026 1133600349 CMS
Gilead Sciences, Inc. $145.56 03/08/2024 Food and Beverage Undisputed 01/23/2026 1133841128 CMS
Gilead Sciences, Inc. $8,123.03 05/14/2024 Consulting Fee Undisputed 01/23/2026 1133600351 CMS
Gilead Sciences, Inc. $23.00 05/30/2024 Travel and Lodging Undisputed 01/23/2026 1133870363 CMS
Gilead Sciences, Inc. $2,540.00 07/23/2024 Consulting Fee Undisputed 01/23/2026 1133600353 CMS
Lilly USA, LLC $2,400.00 07/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135115459 CMS
Merck Sharp & Dohme LLC $41.97 05/17/2024 Travel and Lodging Undisputed 01/23/2026 1141671787 CMS
Merck Sharp & Dohme LLC $32.15 05/17/2024 Food and Beverage Undisputed 01/23/2026 1141671789 CMS
Merck Sharp & Dohme LLC $128.59 05/17/2024 Travel and Lodging Undisputed 01/23/2026 1141861620 CMS
Merck Sharp & Dohme LLC $150.00 05/27/2024 Travel and Lodging Undisputed 01/23/2026 1141572131 CMS
Merck Sharp & Dohme LLC $4,270.00 05/27/2024 Consulting Fee Undisputed 01/23/2026 1141572133 CMS
Novartis Pharma AG $2,700.00 01/10/2024 Consulting Fee Undisputed 01/23/2026 1152815195 CMS
Novartis Pharmaceuticals Corporation $2,200.00 05/31/2024 Consulting Fee Undisputed 01/23/2026 1087106232 CMS
Novartis Pharmaceuticals Corporation $98.77 05/31/2024 Food and Beverage Undisputed 01/23/2026 1087106234 CMS
Novartis Pharmaceuticals Corporation $45.41 06/03/2024 Food and Beverage Undisputed 01/23/2026 1087106244 CMS
Stemline Therapeutics Inc. $170.88 03/08/2024 Food and Beverage Undisputed 01/23/2026 1142961399 CMS
Stemline Therapeutics Inc. $137.72 05/30/2024 Food and Beverage Undisputed 01/23/2026 1142961403 CMS
Stemline Therapeutics Inc. $2,340.00 06/28/2024 Consulting Fee Undisputed 01/23/2026 1142961405 CMS
Stemline Therapeutics Inc. $2,340.00 06/28/2024 Consulting Fee Undisputed 01/23/2026 1142961407 CMS
Stemline Therapeutics Inc. $12.99 07/12/2024 Honoraria Undisputed 01/23/2026 1142961401 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.